Welcome! At Dermagnostix R&D we aim for...
…offering translational scientific solutions in dermatology.
…molecular support of diagnosing skin diseases.
…prediction of treatment response in inflammatory and malignant skin diseases.
…identifying druggable targets and developing efficacious substances for the treatment of skin diseases
Dermatology - a small discipline hits the big time
Seven out of the 15 best-selling drugs worldwide are used in dermatology.
Dermatology is a fascinating discipline which has awakened from its sleeping beauty slumber and started a tremendous revolution. Big data, AI and molecular biology have disrupted dermatology: Deep learning algorithms even surpassing experts in diagnosing skin cancer, the birth of tele-dermatology and a broad palette of specific therapies are just some highlights.
This revolution has eagerly been awaited for as one third of the population worldwide suffers from at least one active skin condition. Although patients can now be treated better than ever before, only a small proportion of patients in dermatology participates in this revolution. Why?
... The current classification of skin diseases does not sufficiently acknowledge the heterogeneity and a complexity of skin diseases.
… Objective biomarkers for skin diseases are mostly amiss and there are no concepts to broadly establish molecular diagnostics for all patients everywhere.
… There are no tools to predict individual course and comorbidities of a disease as well as therapeutic outcome.
... Novel therapeutics fall short of efficacy due to study designs not considering individual molecular patient profiles.
Dermagnostix R&D offers ...
... collaborative research projects with academia, biotech, or pharmaceutical industry to discover and validate novel relevant biomarkers and therapeutic molecules.
… a constantly updated, comprehensive biomarker compendium tailored to the needs of dermatologists and pathologists.
… network and diagnostic devices to implement molecular diagnostics in dermatology.
PD Dr. med. Natalie Garzorz-Stark, PhD, MHBA
Dermatologist
Prof. Dr. med. Kilian Eyerich, PhD
Dermatologist
Prof. Dr. med. Kristian Reich
Dermatologist
Prof. Dr. med. Christoffer Gebhardt
Dermatologist
Dr.-Ing. Katharina Dormanns
Microfluidics Engineer
Dermagnostix R&D discovers and exploits molecular markers in dermatology – to facilitate precision medicine in dermatology. Dermagnostix R&D aims for discovery of novel modes of action to treat common molecular endotypes across diseases. Dermagnostix R&D brings together the best knowledge, expertise, visionary thinking and creativity from key opinion leaders and recognized scientists to have all patients benefit from this revolution.
Publications
